Although the sample size of this lung adenocarcinoma cohort is too small to obtain reliable numbers for low abundant deletion and inactivating mutation frequencies in most other RASGAP genes, inactivating mutations in RASA1 seem, like NF1, mutual exclusive with other activating mutations of the MAPK signaling pathway (Figure 1A). The gene discussed is RASA1; the disease is lung adenocarcinoma.